{"id":"W1987514490","doi":"10.1161/circresaha.112.276741","title":"Oral Direct Factor Xa Inhibitors","year":2012,"lang":"en","type":"review","venue":"Circulation Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Rivaroxaban; Apixaban; Edoxaban; Warfarin; Medicine; Intensive care medicine; Dabigatran; Discovery and development of direct thrombin inhibitors; Pharmacodynamics; Anticoagulant; Pharmacology; Vitamin K antagonist; Thrombin; Atrial fibrillation; Internal medicine; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004144107,0.001048681,0.001439288,0.00201494,0.0002996858,0.001023418,0.0008265837,0.001062153,0.008107726],"category_scores_gemma":[0.000989205,0.0002431385,0.0006524601,0.001575031,0.0003599637,0.0009739613,0.0005863667,0.001714944,0.006159889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004259079,"about_ca_system_score_gemma":0.0008118586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001061625,"about_ca_topic_score_gemma":0.001567057,"domain_scores_codex":[0.9995521,0.00005806347,0.00005982981,0.00007461578,0.0002172372,0.00003822413],"domain_scores_gemma":[0.9997293,0.0001057755,0.00006076387,0.00001272835,0.00006786203,0.00002356803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005949796,0.0000662411,0.0001345969,0.007554333,0.00009961744,0.0002141883,0.0000322552,0.0001052305,0.000970846,0.001710049,0.04825846,0.9407948],"study_design_scores_gemma":[0.00003827488,0.00005118615,0.0005596793,0.002289249,0.00009516298,0.002032848,0.00002230094,0.00003395892,0.0004602301,0.0008942639,0.9935139,0.000008789255],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001431493,0.9940539,0.0002535761,0.0003422342,0.0003508422,0.00001145793,0.00004354585,0.00001755118,0.00478378],"genre_scores_gemma":[0.0016103,0.9935117,0.0003539913,0.0004732231,0.0004239403,0.00001700375,0.00009131977,0.000003013117,0.00351539],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008107726,"threshold_uncertainty_score":0.02712303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.626058490618074,"score_gpt":0.5528008094413012,"score_spread":0.07325768117677278,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}